JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

Bibliographical data

Original languageEnglish
ISSN0887-6924
DOIs
Publication statusPublished - 01.08.2014
PubMed 24569777